Lipocine
LPCN
LPCN
42 hedge funds and large institutions have $12.4M invested in Lipocine in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% more capital invested
Capital invested by funds: $11.5M → $12.4M (+$908K)
0.21% less ownership
Funds ownership: 0.76% → 0.55% (-0.21%)
Holders
42
Holding in Top 10
–
Calls
$2.51M
Puts
$789K
Top Buyers
| 1 | +$231K | |
| 2 | +$135K | |
| 3 | +$106K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$83K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$80.9K |
Top Sellers
| 1 | -$453K | |
| 2 | -$199K | |
| 3 | -$150K | |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
-$121K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$90.5K |